Lion Point Capital, LP Portfolio Holdings

Lion Point Capital, LP

  • $8.91 Million
  • Q2 2025

Lion Point Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $8.91 Million distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Fennec Pharmaceuticals Inc. with a value of $1.62M, Ardelyx, Inc. with a value of $1.31M, Bridge Bio Pharma, Inc. with a value of $1.12M, Insmed Inc with a value of $1.07M, and Milestone Pharmaceuticals Inc. with a value of $1.06M.

Examining the 13F form we can see an decrease of $820K in the current position value, from $9.73M to 8.91M.

Lion Point Capital, LP is based out at New York, NY

Below you can find more details about Lion Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $8.91 Million
Healthcare: $8.91 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$866M
$1.31 Million 14.76% of portfolio
335,400
Q4 2024 Reduced 9.35%
$510M
$705,000 7.92% of portfolio
500,000
Q4 2024 Reduced 20.63%
$887M
$649,000 7.29% of portfolio
46,300
Q4 2024 Added 31.91%
$734M
$515,000 5.78% of portfolio
55,000
Q4 2024 Added 19.05%
$350M
$474,000 5.32% of portfolio
57,750
Q3 2024 Added 59.31%
$590M
$193,000 2.17% of portfolio
644,000
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $8.91 Million
  • Prior Value $9.73 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Lion Point Capital, LP Portfolio

Follow Lion Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lion Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email